Glenmark Pharmaceuticals, Sanofi (France) in $345 Million Drug-Licensing Pact
WSJ -- India's Glenmark Pharmaceuticals Ltd. said Monday it has agreed to license out development and commercialization rights of a painkiller it is developing to France's Sanofi-Aventis S.A.